Abstract
Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008
| Original language | English (US) |
|---|---|
| Title of host publication | xPharm |
| Subtitle of host publication | The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-6 |
| Number of pages | 6 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - Jan 1 2008 |
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Fingerprint Dive into the research topics of 'Fondaparinux'. Together they form a unique fingerprint.
Cite this
Sindhu, S., & Silberstein, P. (2008). Fondaparinux. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-6). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.64063-2